PROCTER & GAMBLE HEALTH | KOPRAN. | PROCTER & GAMBLE HEALTH/ KOPRAN. |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | 30.4 | 113.7% | View Chart |
P/BV | x | 10.6 | 2.8 | 377.2% | View Chart |
Dividend Yield | % | 2.0 | 1.2 | 170.9% |
PROCTER & GAMBLE HEALTH KOPRAN. |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
KOPRAN. Mar-23 |
PROCTER & GAMBLE HEALTH/ KOPRAN. |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 327 | 1,639.1% | |
Low | Rs | 3,883 | 96 | 4,044.8% | |
Sales per share (Unadj.) | Rs | 740.7 | 114.3 | 648.1% | |
Earnings per share (Unadj.) | Rs | 138.2 | 5.6 | 2,447.1% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 8.3 | 1,872.7% | |
Dividends per share (Unadj.) | Rs | 95.00 | 3.00 | 3,166.7% | |
Avg Dividend yield | % | 2.1 | 1.4 | 145.0% | |
Book value per share (Unadj.) | Rs | 447.6 | 91.1 | 491.3% | |
Shares outstanding (eoy) | m | 16.60 | 48.21 | 34.4% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 1.9 | 337.1% | |
Avg P/E ratio | x | 33.5 | 37.5 | 89.3% | |
P/CF ratio (eoy) | x | 29.8 | 25.5 | 116.7% | |
Price / Book Value ratio | x | 10.3 | 2.3 | 444.6% | |
Dividend payout | % | 68.7 | 53.1 | 129.4% | |
Avg Mkt Cap | Rs m | 76,761 | 10,205 | 752.2% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 499 | 412.8% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 5,510 | 223.2% | |
Other income | Rs m | 184 | 31 | 600.0% | |
Total revenues | Rs m | 12,480 | 5,541 | 225.3% | |
Gross profit | Rs m | 3,247 | 518 | 626.8% | |
Depreciation | Rs m | 281 | 127 | 221.1% | |
Interest | Rs m | 8 | 61 | 12.7% | |
Profit before tax | Rs m | 3,142 | 361 | 871.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 88 | 959.2% | |
Profit after tax | Rs m | 2,295 | 272 | 842.6% | |
Gross profit margin | % | 26.4 | 9.4 | 280.9% | |
Effective tax rate | % | 27.0 | 24.5 | 110.1% | |
Net profit margin | % | 18.7 | 4.9 | 377.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 3,991 | 293.5% | |
Current liabilities | Rs m | 6,791 | 1,770 | 383.7% | |
Net working cap to sales | % | 40.0 | 40.3 | 99.3% | |
Current ratio | x | 1.7 | 2.3 | 76.5% | |
Inventory Days | Days | 263 | 11 | 2,469.8% | |
Debtors Days | Days | 343 | 1,077 | 31.9% | |
Net fixed assets | Rs m | 10,617 | 2,506 | 423.6% | |
Share capital | Rs m | 166 | 482 | 34.4% | |
"Free" reserves | Rs m | 7,265 | 3,910 | 185.8% | |
Net worth | Rs m | 7,431 | 4,392 | 169.2% | |
Long term debt | Rs m | 0 | 179 | 0.0% | |
Total assets | Rs m | 22,330 | 6,497 | 343.7% | |
Interest coverage | x | 409.1 | 6.9 | 5,903.5% | |
Debt to equity ratio | x | 0 | 0 | 0.0% | |
Sales to assets ratio | x | 0.6 | 0.8 | 64.9% | |
Return on assets | % | 10.3 | 5.1 | 201.1% | |
Return on equity | % | 30.9 | 6.2 | 498.1% | |
Return on capital | % | 42.4 | 9.2 | 459.7% | |
Exports to sales | % | 0 | 44.7 | 0.0% | |
Imports to sales | % | 13.1 | 10.1 | 129.0% | |
Exports (fob) | Rs m | NA | 2,464 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 558 | 287.8% | |
Fx inflow | Rs m | 1,465 | 2,464 | 59.5% | |
Fx outflow | Rs m | 1,605 | 624 | 257.1% | |
Net fx | Rs m | -140 | 1,840 | -7.6% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 340 | 693.6% | |
From Investments | Rs m | -215 | -127 | 170.0% | |
From Financial Activity | Rs m | -985 | -198 | 496.2% | |
Net Cashflow | Rs m | 1,160 | 15 | 7,593.6% |
Indian Promoters | % | 0.0 | 44.5 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 2.0 | 978.9% | |
FIIs | % | 6.2 | 0.8 | 742.9% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 55.5 | 86.8% | |
Shareholders | 56,778 | 50,850 | 111.7% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | KOPRAN. | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | -1.68% | 0.45% |
1-Month | -1.15% | 2.64% | 2.55% |
1-Year | 0.73% | 64.50% | 56.14% |
3-Year CAGR | -8.76% | 15.61% | 15.22% |
5-Year CAGR | 4.97% | 45.31% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the KOPRAN. share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of KOPRAN. the stake stands at 44.5%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of KOPRAN..
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
KOPRAN. paid Rs 3.0, and its dividend payout ratio stood at 53.1%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of KOPRAN..
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.